Blocknomi
TLDR JNJ offers $5.5B settlement covering about 76,000 talc cancer claims. JNJ stock rises after proposed deal targets long-running talc litigation. Settlement needs 95% claimant approval before becoming final.…
Related articles
-
Robinhood Leads Tokenized Stocks by Holders but Not by Money
BeInCrypto Published 28.07.2026 09:45
-
SBI Holdings Secures Coinhako Majority Stake After Singapore Regulatory Green Light
Blocknomi Published 17.07.2026 11:03
-
3 Altcoins Decline as Binance Flags Delisting Risk
BeInCrypto Published 24.07.2026 04:06
-
General Dynamics (GD) Stock Surges to 52-Week Peak in July 2026
Blocknomi Published 23.07.2026 17:11
-
Hester Peirce Warns Crypto Vaults And Lending Strategies May Still Trigger Securities Rules
NewsBTC Published 24.07.2026 18:10
-
AlphaX Rolls Out Global Zero-Fee Trading Initiative Across TradFi and Crypto Markets
BeInCrypto Published 15.07.2026 07:22
-
Court Signs Off on Record $1.5 Billion Anthropic Copyright Payout
BeInCrypto Published 21.07.2026 04:20
-
Bitcoin gets new $80K August target: Watch these BTC price levels next
Cointelegraph Published 15.07.2026 10:22